• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS25
Device Problem Leak/Splash (1354)
Patient Problem Aortic Regurgitation (1716)
Event Date 08/24/2020
Event Type  Injury  
Event Description
On (b)(6) 2020 a patient received a perceval pvs25 sutureless aortic heart valve as part of an avr.No issues were identified with the indwelled position and shape, the aorta was closed and checked via transesophageal echo, but regurgitation was observed in area from rcc to ncc.Since no indwelling position misalignment or valve opening/closing abnormalities were observed on the short-axis image, it was decided to perform a re-implantation.When the perceval was exposed, the annulus distortion and leaflet distortion were checked, but they could not be confirmed.Some portion of the valve appeared small.The valve was analyzed after explant and a section of leaflet at the cusp seemed to be shorter.When sizing was performed again and another perceval (same size, l) was indwelled, the implant was successful without any problems.Extended extracorporeal circulation time was 20 minutes.No problem observed after the procedure.The patient is currently being followed.
 
Manufacturer Narrative
The device was returned for analysis.The returned valve prosthesis appears in general good storage conditions.The visual inspection performed on the returned prosthesis confirmed the absence of pre-existing defects.The leaflet height verification confirmed the compliance of this dimensional parameter.The go-no go test confirmed the absence of dimensional irregularity.The deployment simulations and the static leak tests, performed on the returned valve, did not highlight evidence of paravalvular leaks.Based on the performed analyses, it is possible to exclude any relationship between the device and the reported issue as no device related malfunctions or abnormalities were detected.The manufacturer is presently performing a review of the device history records to ensure the device met all required standards at the time of manufacture and release.
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1210, s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by quality engineering at livanova canada corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1210) perceval heart valve at the time of manufacture and release.Based on the performed analyses, it is possible to exclude any relationship between the device and the reported issue as no device related malfunctions or abnormalities were detected.The returned prosthesis satisfied all the manufacturing requirements at the time of manufacture and release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc
MDR Report Key10578180
MDR Text Key208312818
Report Number1718850-2020-01150
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup,Followup
Report Date 08/24/2020,12/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/10/2020
Was the Report Sent to FDA? No
Distributor Facility Aware Date11/16/2020
Event Location Hospital
Date Report to Manufacturer08/24/2020
Date Manufacturer Received08/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient Weight62
-
-